% Generated by roxygen2: do not edit by hand
% Please edit documentation in R/lipid_markers.R
\name{lipid_markers}
\alias{lipid_markers}
\title{Calculate lipid-panel markers, Visceral Adiposity Index (VAI),
Lipid Accumulation Product (LAP), and TyG–BMI index}
\usage{
lipid_markers(
  data,
  col_map = list(TC = "TC", HDL_c = "HDL_c", TG = "TG", LDL_c = "LDL_c", ApoB = "ApoB",
    ApoA1 = "ApoA1", waist = NULL, BMI = NULL),
  verbose = FALSE
)
}
\arguments{
\item{data}{A \code{data.frame} or \code{tibble} containing your lipid
(and optional anthropometry/glucose) data.}

\item{col_map}{Named list mapping:
\itemize{
\item \code{TC}    → total cholesterol
\item \code{HDL_c} → HDL-C
\item \code{TG}    → triglycerides
\item \code{LDL_c} → (optional) LDL-C; if missing, estimated via Friedewald
\item \code{ApoB}, \code{ApoA1} → (optional) apolipoproteins
\item \code{waist} → (optional) waist circumference (cm)
\item \code{BMI}   → (optional) body mass index (kg/m²)
}}

\item{verbose}{Logical; if \code{TRUE}, prints a message about computing markers.}
}
\value{
A tibble with:
\itemize{
\item \code{non_HDL_c}, \code{remnant_c}
\item \code{ratio_TC_HDL}, \code{ratio_TG_HDL}, \code{ratio_LDL_HDL}
\item \code{ApoB_ApoA1}
\item \code{VAI_Men}, \code{VAI_Women}
\item \code{LAP_Men}, \code{LAP_Women}
\item \code{TyG_BMI}
}
}
\description{
Given total cholesterol, HDL, TG (and optionally LDL, ApoB/ApoA1,
waist, BMI, glucose), computes:
\itemize{
\item \code{non_HDL_c}, \code{remnant_c}
\item \code{ratio_TC_HDL}, \code{ratio_TG_HDL}, \code{ratio_LDL_HDL}
\item \code{ApoB_ApoA1}
\item \code{VAI_Men}, \code{VAI_Women}
\item \code{LAP_Men}, \code{LAP_Women}
\item \code{TyG_BMI}
}
}
\references{
\itemize{
\item Friedewald WT, Levy RI, Fredrickson DS. Estimation of the
concentration of LDL cholesterol in plasma, without use of
preparative ultracentrifuge. \emph{Clin Chem}. 1972;18(6):499–502.
\item Amato MC, Giordano C, Galia M, et al. Visceral adiposity index:
a reliable indicator of visceral fat function associated with
cardiometabolic risk. \emph{Diabetes Care}. 2010;33(4):920–922.
\item Kahn HS. Lipid accumulation product performs better than BMI as
a marker of cardiovascular risk. \emph{J Clin Endocrinol Metab}.
2005;90(11):6292–6298.
\item Lee YH, Kim JE, et al. Triglyceride-glucose-body mass index
(TyG-BMI) predicts nonalcoholic fatty liver disease. \emph{Int J Obes}.
2020;44(9):2101–2110.
}
}
